Home / SME Stocks / Nidan Laboratories and Healthcare
Nidan Laboratories and Healthcare: IPO, Share Price and Results Since Listing
For H1 FY2027 it reported revenue of INR 12.02 crore (-8.41% on a year earlier) and a profit after tax of INR 1.09 crore.
Key Facts
- Listed on NSE Emerge
- 12 November 2021
- Symbol
- NIDAN
- Latest close
- INR 13.15 on 11 November 2026
- Lot size now
- 1,000 shares (INR 13,150 at the latest close)
Results Filed With NSE
Standalone figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H1 FY2027 | 12.02 | -8.41% | 1.09 | 0.80 | after listing | 5 November 2026 |
| H2 FY2026 | 12.42 | -11.25% | 0.07 | 0.05 | after listing | 25 May 2026 |
| FY2026 | 25.54 | +4.13% | 1.51 | 1.08 | after listing | 25 May 2026 |
| H1 FY2026 | 13.12 | – | 1.43 | 1.03 | after listing | 10 November 2025 |
| H2 FY2025 | 13.99 | – | 0.88 | 0.63 | after listing | 28 May 2025 |
| FY2025 | 24.53 | – | 1.98 | 1.42 | after listing | 28 May 2025 |
Promoter Holding
Promoter holding has moved from 71.22% on 31 March 2023 to 57.04% on 30 September 2026 (-14.18 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 57.04% | 42.96% |
| 30 June 2026 | 57.04% | 42.96% |
| 31 March 2026 | 57.04% | 42.96% |
| 31 December 2025 | 57.04% | 42.96% |
| 30 September 2025 | 57.04% | 42.96% |
| 31 March 2025 | 57.04% | 42.96% |
| 30 September 2024 | 57.04% | 42.96% |
| 31 March 2024 | 57.04% | 42.96% |
| 30 September 2023 | 62.79% | 37.21% |
| 31 March 2023 | 71.22% | 28.78% |
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.